Sort by
Refine Your Search
-
A Postdoctoral position is available in the laboratory of Dr. Jamie Anastas, Assistant Professor in the Department of Neurosurgery and at the Center for Cell and Gene Therapy at Baylor College
-
Postdoctoral positions are available in the laboratory of Dr. Jeremy Wang, Ralph L Brinster President’s Distinguished Professor, at the University of Pennsylvania to study meiosis and spermatogonial
-
The Section of Epidemiology and Population Sciences at Baylor College of Medicine invites applications for postdoctoral research in systems epidemiology of cancer. This is a 3-year flexible program
-
We are looking for a highly motivated postdoctoral researcher to join the laboratory of Professor A. Claudio Cuello at McGill University’s Department of Pharmacology and Therapeutics
-
leading hub of innovative anti-cancer and immuno-oncology drug development. We currently have multiple postdoctoral fellowship positions available within our multidisciplinary research teams based In Hong
-
research priorities: Economies of the future, Health & Wellness, Sustainable environment & Essential needs, Energy & Industrial Leadership. The KAUST Global Postdoctoral Fellowship Program is one of several
-
The Department of Family and Community Medicine at Baylor College of Medicine is offering an innovative full-time primary care research fellowship to doctoral students, including those with clinical and non-clinical research degrees. This fellowship features a two-year core curriculum,...
-
We are seeking 2 highly motivated postdoctoral fellows with background in either development/stem cell, neuroscience, craniofacial biology to join NIH-funded Jian-Fu Chen laboratory at Center
-
We are developing gene therapy for Alzheimer's disease targeting the earliest stages of dementia. Our approach leverages AAV as a Trojan horse to overcome the challenges of delivering peptide inhibitors across the blood-brain barrier. Proof-of-principle in genetically engineered mouse models...
-
for postdoctoral fellows who would like to engineer next-generation T cell therapies for solid tumors. Adoptive cell therapies have revolutionized the treatment of aggressive hematological malignancies. However